About 1.9 million people in the United States have type 1 diabetes, including an estimated 244,000 kids and teens, according ...

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

The firm is also studying PTG-007 in patients with early-stage type 1 diabetes, but is looking for a partner for the pivotal trial.

Worldwide, the condition is estimated to have an annual economic impact of approximately $1 trillion, around 1 percent of the global economy.

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look ...